The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis

Clinical trial NCT05092113 · UNKNOWN

Trial details

NCT number: NCT05092113
Sponsor: Meng Qiu
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Mucositis Chemotherapeutic Toxicity

Start date: 2021-06-30
Primary completion: 2022-12-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.